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PURPOSE: To summarize and compare the published data on gadolinium-enhanced
magnetic resonance (MR) angiography and color-guided duplex ultrasonography
(US) for the work-up for peripheral arterial disease.
MATERIALS AND METHODS: Studies published between January 1984 and
November 1998 were included if (a) gadolinium-enhanced MR angiography and/or
color-guided duplex US were performed for evaluation of arterial stenoses and
occlusions in the work-up for peripheral arterial disease of the lower extremities,
(b) conventional angiography was the reference standard, and (c) absolute numbers
of true-positive, false-negative, true-negative, and false-positive results were avail-
able or derivable.
RESULTS: With a random effects model, pooled sensitivity for MR angiography
(97.5% [95% CI: 95.7%, 99.3%]) was higher than that for duplex US (87.6% [95%
CI: 84.4%, 90.8%]). Pooled specificities were similar: 96.2% (95% CI: 94.4%,
97.9%) for MR angiography and 94.7% (95% CI: 93.2%, 96.2%) for duplex US.
Summary receiver operating characteristic analysis demonstrated better discrimina-
tory power for MR angiography than for duplex US. Regression coefficients for MR
angiography versus US were 1.67 (95% CI: 20.23, 3.56) with adjustment for
covariates, 2.11 (95% CI: 0.12, 4.09) without such adjustment, and 1.73 (95% CI:
0.44, 3.02) with a random effects model.
CONCLUSION: Gadolinium-enhanced MR angiography has better discriminatory
power than does color-guided duplex US and is a highly sensitive and specific
method, as compared with conventional angiography, for the work-up for peripheral
arterial disease.
The assessment of lifestyle-limiting intermittent claudication and critical ischemia prior to
revascularization has traditionally been performed with conventional angiography. Con-
ventional angiography is a widely used imaging modality that yields a ‘‘road map’’ of the
vascular system, which is useful in choosing the optimal type and technique of revascular-
ization procedure. Angiography is, however, an invasive procedure with a risk of morbidity
and mortality (1,2). When possible, noninvasive methods are used in the initial assessment
of peripheral arterial disease.
Duplex ultrasonography (US) has been shown to be a reliable noninvasive modality with
fairly good sensitivity and specificity (3). The addition of color flow imaging to help guide
duplex scanning improves the diagnostic performance (4). Duplex US is, however, operator
dependent and labor intensive and does not provide a road map equivalent to that obtained
with angiography. Gadolinium-enhanced magnetic resonance (MR) angiography is a
relatively new minimally invasive imaging method used for the work-up of peripheral
arterial disease. Intravenous administration of a gadolinium chelate is considered to be
safe, and MR angiography provides high-quality three-dimensional images of the vascular
system in a short time with high sensitivity and specificity (5–11). Disadvantages of MR
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angiography are the expense and the small
number of cases in which the procedure is
unsuccessful due to susceptibility artifacts
or because the patient has claustrophobia.
A number of articles have recently been
published on the topic of gadolinium-
enhanced MR angiography, each a report
of the experience from a single center
with a limited number of patients. Before
supporting MR angiography as a substi-
tute for conventional (x-ray) angiogra-
phy, the overall combined evidence
should demonstrate whether MR angiog-
raphy is a highly sensitive and specific
modality. Furthermore, we are aware of
no reports in which gadolinium-enhanced
MR angiography was compared with
color-guided duplex US. If a choice must
be made between the imaging modalities,
it should be largely dependent on the
reported diagnostic accuracies of both
methods, taking into account differences
in applied positivity criteria and patient
characteristics. A powerful tool for this
kind of analysis is summary receiver oper-
ating characteristic (ROC) analysis (12–14).
The purpose of this study was to sum-
marize and compare the diagnostic perfor-
mance of gadolinium-enhanced MR angi-
ography and color-guided duplex US for
the evaluation of arterial stenoses and
occlusions in the work-up of peripheral
arterial disease of the lower extremities
and to compare both methods with con-
ventional angiography.
MATERIALS AND METHODS
Data Sources and Data Extraction
A search was performed of the medical
literature for articles on gadolinium-
enhanced MR angiography and color-
guided duplex US that were published
between January 1984 and November
1998 (14). For the period between Janu-
ary 1984 and June 1994, we used articles
on color-guided duplex US included in a
previously published meta-analysis (4,15–
20). For gadolinium-enhanced MR angiog-
raphy, we limited the search to articles
published between January 1990 and No-
vember 1998 because gadolinium-en-
hanced MR angiography was introduced
in the early 1990s. A Medline search was
performed by using the following key-
words and words related to these key-
words: peripheral vascular, arterial occlu-
sive, peripheral arterial, leg, limb, lower
extremity, popliteal, femoral, and iliac,
combined with MR angiography, mag-
netic resonance, duplex, Doppler, and
ultrasonography. Additional references
were obtained from bibliographies of re-
views and original articles, and experts in
the field were consulted. The PubMed
search engine was used to find the most
recently published articles.
Articles (5–11,15–39) were included in
the analysis if they met the following
criteria: (a) Gadolinium-enhanced MR an-
giography, color-guided duplex US, or
both, were performed to demonstrate ste-
noses and occlusions of the arteries in the
lower extremities; (b) results of conven-
tional angiography were used as the refer-
ence standard; and (c) the absolute num-
bers of true-positive (TP), false-negative
TABLE 1
Summary of MR Angiography Characteristics of Included Studies
Study*
Year of
Publication
Study
Location MR Parameters† Imager
Gadolinium
Dose
(mmol/kg)
Adamis et al (7) 1995 North America 2D fast inflow with steady-state
precession (291/7, 60°–90° flip
angle); subtraction MIP
1.5 T, body coil (Siemens Medical
Systems, Erlangen, Germany)
0.3
Hany et al (6) 1997 Europe 3D spoiled GRE (4/1.9, 40° flip
angle); MIP, multiplanar refor-
mations
1.5 T, surface coil (Signa; GE
Medical Systems, Milwaukee,
Wis)
0.3
Ho et al (11)‡ 1998 Europe Moving-bed infusion-tracking 3D
fast field echo (14.1/6.1, 50° flip
angle); subtraction MIP
1.5 T, body coil (Gyroscan; Philips
Medical Systems, Best, the
Netherlands)
0.3§
Ho et al (10)‡ 1998 Europe 3D fast field echo (20/6, 60° flip
angle); subtraction and non-
subtraction MIP
1.5 T, body coil (Gyroscan; Philips
Medical Systems)
0.2§
Laissy et al (34) 1998 Europe 2D fast low-angle shot (108/4, 65°
flip angle); subtraction MIP
1 T, body coil (Magnetom;
Siemens Medical Systems)
0.2
Poon et al (8) 1997 North America 3D GRE (32/5, 40° flip angle); MIP 1.5 T, body coil (Gyroscan; Philips
Medical Systems)
0.3§
Quinn et al (38) 1997 North America 3D time of flight (25/6.9, 40° flip
angle); MIP
1.5 T, body coil (Signa; GE
Medical Systems)
0.2
Rofsky et al (9) 1997 North America 3D GRE (5/2, 30°–50° flip angle);
subtraction MIP
1.5 T, body coil (Vision; Siemens
Medical Systems)
0.2
Snidow et al (5) 1996 North America 3D GRE (7/2.8, 60° flip angle);
MIP
1.5 T, body coil (Edge; Picker,
Highland Heights, Ohio)
0.2§
Cambria et al (26)\ 1997 North America 2D spoiled GRE (29/6.7, 45°–60°
flip angle), gadolinium-en-
hanced 3D spoiled GRE (24/6.9,
40° flip angle); MIP#
1.5 T, body and head coils (Signa;
GE Medical Systems)
0.3
Note.—The reduction in vessel diameter was considered to be greater than 50% in all studies.
* Number in parentheses is the reference number.
† Numbers separated by the virgule are repetition time msec/echo time msec. GRE 5 gradient recalled echo, MIP 5 maximum intensity projection,
2D 5 two-dimensional, 3D 5 three-dimensional.
‡ Studies did not include overlap in patients (Ho KY, personal communication, 1998).
§ Dose is an estimate determined from reported volume of injection and assumption of 70-kg body weight.
\ Study was used only for the sensitivity analysis.
# In 37% of patients, 3D gadolinium-enhanced MR angiography was performed because of tortuosity or aneurysm of iliac arteries that caused severe
saturation artifacts on 2D time-of-flight images.
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(FN), true-negative (TN), and false-posi-
tive (FP) results were available or could be
derived for a defined cutoff criterion for
angiography—usually a reduction in arte-
rial diameter of more than 50%. In the
case of multiple published reports by the
same author(s) over a brief time, we tried
to contact the author(s) to determine
whether the patient populations over-
lapped. Use of the same patient popula-
tion more than once in our analysis could
bias the results. Among the articles
(6,23,28,39–41) in which data were re-
ported for the same patient population,
we included those (6,23,39) with a re-
search question most relevant to our meta-
analysis. Moreover, we tried to contact
the authors of articles that reported a
measure of agreement (eg, k statistic)
between the comparison modality and
angiography rather than the absolute
numbers of TP, FN, TN, and FP results.
One author (26) gave us the relevant data,
but two (5,42) neglected to reply despite
repeated requests (total of three requests
to each).
Each author independently extracted
the data from all articles by using a stan-
dardized spreadsheet. The authors were
not blinded with regard to identifying
information of the individual manu-
scripts because this has been shown to be
unnecessary (43). Extracted data included
variables related to study design, patient
characteristics, diagnostic imaging proto-
col, and absolute numbers of TP, FN, TN,
and FP results (Tables 1–4). The absolute
numbers were most often available for
arterial segments rather than for limbs or
patients. If the results were tabulated for
different readers, then the results of the
first reader were used. If more than one
examination technique was presented in
the same article, we used the technique
advised by the authors. US results for iliac
segments were excluded if stenoses were
indirectly determined on the basis of
Doppler waveform analysis results for the
common femoral arteries. MR angio-
graphic results for segments examined
with time-of-flight or phase-contrast tech-
TABLE 2
Summary of Duplex US Characteristics of Included Studies
Study*
Year of
Publication Location
Diameter
Reduction (%) US Criteria† Scanner and Manufacturer
AbuRhama et al (22) 1995 North America . 50 PSV ratio . 2 or PSV . 200
cm/sec in iliac artery
Ultramark 9; ATL Ultrasound,
Bothell, Wash
Aly et al (23) 1998 Europe . 50 PSV ratio . 2 Model 128; Acuson, Mountain
View, Calif
Arya (24) 1996 Asia . 50 PSV ratio . 2, loss of reverse flow,
or spectral broadening
Ultramark 9; ATL Ultrasound
Bergamini et al (25) 1995 North America . 50 PSV ratio . 2 QAD-1; Quantum Medical
Systems, Woodland Hills, Calif
Cossman et al (15) 1989 North America . 50 PSV ratio . 2 or PSV . 200
cm/sec
Model 128; Acuson
Davies et al (16) 1992 Europe . 50 PSV ratio . 2, loss of reverse flow,
or spectral broadening
Ultramark 9; ATL Ultrasound
Karacagil et al (30)‡ 1996 Europe . 50 PSV ratio . 2 Model 128; Acuson
Karacagil et al (29)‡ 1994 Europe . 50 PSV ratio . 2 Sonos 1000; Hewlett-Packard,
Andover, Mass
Lai et al (33) 1996 Australia . 50 PSV ratio . 2 or PSV . 200
cm/sec
Ultramark 9; ATL Ultrasound
Larch et al (35) 1997 Europe . 50 PSV ratio . 2 Acuson
Linke et al (36) 1994 Australia . 50 PSV ratio . 2 or PSV . 200
cm/sec
Model 128; Acuson
Moneta et al (17) 1993 North America . 50 PSV ratio . 2 or PSV . 200
cm/sec in iliac artery
Model 128; Acuson
Mulligan et al (18) 1991 North America . 50 PSV ratio . 2 Model 128; Acuson
Pinto et al (37) 1996 Europe . 50 PSV ratio . 2, spectral broad-
ening, or flattening of triphasic
waveform
AU 590A or AU4; Esaote Bio-
medica, Genoa, Italy
Polak et al (19) 1990 North America . 50 PSV ratio . 2 or luminal nar-
rowing
Acuson
Sensier et al (41) 1996 Europe . 50 PSV ratio . 2 Spectra; Diasonics, Tirat Carmel,
Israel
Whelan et al (20) 1992 North America . 50 PSV ratio . 2, PSV . 200 cm/sec,
or loss of reverse flow
Model SSA 270 A; Toshiba,
Tustin, Calif
Zeuchner et al (21) 1994 Europe . 50 PSV ratio . 2 Model SSA 270 A; Toshiba
Sensitivity analysis
Currie et al (27) 1995 Europe . 70§ PSV ratio . 2.5 Ultramark 9; ATL Ultrasound
Koelemay et al (31)\ 1997 Europe Severe irregularities# Vessel wall irregularities at B-mode
US or luminal narrowing
Sonos 1000; Hewlett-Packard
Koelemay et al (32)\ 1998 Europe Severe irregularities# Vessel wall irregularities at B-mode
US or luminal narrowing
Sonos 2000; Hewlett-Packard
* Number in parentheses is the reference number.
† PSV 5 peak systolic velocity. PSV ratio is PSV at stenosis divided by PSV distal to stenosis. Criteria for occlusion were absence of flow and/or color
saturation.
‡ Patient populations assumed not to overlap because different scanners were used.
§ Reduction in area was greater than 50%.
\ Period during which patients were included in the studies did not overlap.
# Positive angiogram demonstrated severe vessel wall irregularities, diffuse luminal narrowing, isolated subtotal stenosis, or occlusion.
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niques and without gadolinium enhance-
ment were excluded from the analysis.
Discrepancies in data extraction be-
tween the two authors were noted and
resolved at consensus. The k value was
calculated as a measure of agreement be-
tween extracted categoric variables in the
analysis, and the correlation coefficient (r
value) was calculated as a measure of
agreement between extracted continuous
variables in the analysis. The natural loga-
rithm of the diagnostic odds ratio (D) was
calculated as follows: D 5 ln[(TP 3 TN)/
(FP 3 FN)]. This value represents a sum-
mary measure of the diagnostic perfor-
mance per study (ie, the discriminatory
power of the examination). This was the
measure of interest in the summary ROC
analysis. The correlation between the
natural logarithms of the diagnostic odds
ratios as derived from the individual stud-
ies by the two authors was calculated to
summarize the overall agreement in the
data extracted by both authors.
Data Synthesis
Funnel plot.—To detect publication bias,
(ie, the bias resulting from studies with a
positive result being published more of-
ten than studies with a negative result),
we constructed a funnel plot (44). In a
funnel plot, the number of units mea-
sured per individual study (arterial seg-
ments, in this case) is plotted as a func-
tion of the measure of interest (the natural
logarithm of the diagnostic odds ratio, in
this case). In the absence of publication
bias, the data points form a symmetric
funnel-shaped distribution, whereas a
skewed and asymmetric distribution indi-
cates the presence of publication bias.
Funnel-plot symmetry was determined
informally by means of visual inspection
of the graph.
Weighted pooled analysis.—Pooled val-
ues for effect size are often calculated by
means of a weighted pooling of the indi-
vidual effect sizes, with weights equal to
the reciprocal of the variance of each
study. To apply this method, the assump-
tion of homogeneity of effect sizes must
hold (45,46). We checked the homogene-
ity of effect sizes with a statistical test,
and only the sensitivity of MR angiogra-
phy was homogeneous. We therefore used
a random effects model, which can ac-
commodate heterogeneous, as well as ho-
mogeneous, effect sizes. The pooled val-
ues based on this model include an
estimated component of variance due to
interstudy variation (45,46). We calcu-
lated the pooled sensitivity, specificity,
and natural logarithm of the diagnostic
odds ratio and constructed 95% CIs.
Summary ROC analysis.—Summary ROC
analysis is a meta-analytic method to
summarize and combine the true- and
false-positive rates for different diagnos-
tic studies (12–14). The method involved
development of a regression model with
the dependent variable being the natural
logarithm of the diagnostic odds ratio
from each study and the independent
variable being a measure of the positivity
criterion (S) of the study (ie, classifica-
tion of an examination as positive): S 5
ln[(TP 3 FP)/(TN 3 FN)]. With this
method, one assumes that the differences
in examination performance reported in
the literature are due partly to variations
in the positivity criterion used by differ-
ent authors; the regression analysis thus
allows one to adjust for these differences.
Adjustment for important clinical vari-
ables and comparison of examinations
are also possible. Examples of meta-
analyses that used a summary ROC analy-
sis can be found in De Vries et al (4) and
Fleischmann et al (47).
The adjustment for clinical variables is
accomplished by including them in the
regression model. Inclusion of a dummy
variable in the regression analysis for the
type of diagnostic examination performed
(1 for MR angiography, 0 for duplex US)
makes it possible to compare the tests.
The regression coefficient of this dummy
variable is a measure of the difference in
discriminatory power between the exam-
inations. A positive regression coefficient
indicates increased discriminatory power
TABLE 3
Clinical Characteristics of Included Studies: MR Angiography
Study*
No. of
Patients†
Mean
Age
(y)
Clinical Indication Arterial Segments
Maximum
Time
between
Examinations
(d)
Consecutive
Patients TP FN TN FP
CL
(%)
CI
(%)
Other
(%)
AI
(%)
F-P
(%)
IP
(%)
Adamis et al (7) 11 (75/25)‡ 67 NR NR NR NR NR NR 14 No 37§ 0 111 19
Hany et al (6) 39 (72/28) 62 100 0 0 100 0 0 2 No 64 2 200 7
Ho et al (11) 28 (82/18) 62 100 0 0 24 46 30 7 Yes 90 7 240 4
Ho et al (10) 28 (75/25) 63 100 0 0 49 51 0 7 Yes 34 3 191 14
Laissy et al (34) 20 (85/15) 53 100 0 0 0 46 54 4 NR 113 0 393 14
Poon et al (8) 15 (80/20) 58 NR NR NR 67 33 0 NR NR 12 0 78 0
Quinn et al (38) 30 (64/36)‡ NR 0 100 0 100 0 0 1 Yes 31 0 86 1
Rofsky et al (9) 15 (60/40) 66 0 100 0 NR NR NR 5 No 37 1 108 4
Snidow et al (5) 30 (98/2)‡ 63\ 36# 38# 26 100 0 0 NR No 27 0 117 6
Sensitivity analysis
Cambria et al (26) 79 (56/44) 70** 43 57 0 16 24 60 NR No 37†† 8 195 16
Note.—All studies included blinded interpretation of both reference images and MR angiograms except that of Rofsky et al (9), who did not report
whether readings were blinded. AI 5 aortoiliac, CI 5 critical ischemia, CL 5 intermittent claudication, F-P 5 femoropopliteal, IP 5 infrapopliteal, NR 5 not
reported.
* Number in parentheses is the reference number.
† Numbers in parentheses are percentage of men/percentage of women.
‡ Percentage of men and women was not reported for verified patients but only for the total number of patients described in the study.
§ Includes bypass graft results.
\ Mean age was not reported for verified patients but only for the total number of patients described in the study.
# Percentage with CL and CI not available because more than one symptom per patient was reported. Values are estimates on the basis of symptoms
per site.
** Because 49.4% of patients were older than 70 years, the estimated mean age was 70 years.
†† F-P and IP segments were depicted on nonenhanced MR angiograms and were, therefore, excluded.
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for MR angiography relative to that of
duplex US, whereas a negative regression
coefficient indicates reduced discrimina-
tory power.
To prevent undefined values for diag-
nostic odds ratios, positivity criteria, and
their variances that result from zero val-
ues for TP, FN, TN, or FP results, 0.5 was
added to each TP, FN, TN, and FP value (13).
We assessed the effect of publication
year; continent (North America vs other),
mean age (65 years or younger vs older
than 65 years), prevalence of diseased
segments per study, blinded interpreta-
tion of the test result (yes or probably vs
no or not reported), blinded interpreta-
tion of the reference test result (yes vs no
or not reported), inclusion of consecutive
patients (yes vs no or not reported), type
of imager (Ultramark [ATL] vs Acuson vs
other for duplex US; Philips Medical Sys-
tems vs Siemens Medical Systems vs other
for MR angiography), and dose of gadolin-
ium (in millimoles per kilogram body
weight) for MR angiography. A quality
score was defined on the basis of the
following criteria: blinded interpretation
of MR or US images, blinded interpreta-
tion of the reference modality results,
and inclusion of consecutive patients.
Studies fulfilling all criteria were given a
quality score of 1; all others were given a
score of 0. Also, a four-tiered rating of
quality for diagnostic imaging studies,
described by Kent et al (48), was deter-
mined for each study and analyzed by
using three dummy variables.
Owing to missing data, the proportion
of patients with intermittent claudica-
tion could not be analyzed as a covariate
and was, therefore, excluded from all
analyses. The proportions of femoropopli-
teal and infrapopliteal segments were
missing for three articles, and only the
subset of articles with complete data for
the relevant variables was used. Age was
not reported in six articles, and another
three reported median age instead of mean
age. The proportion of male patients was
not reported in five articles. The maxi-
mum number of days between MR angiog-
raphy or duplex US and the conventional
angiography was not reported in four
articles. Estimates of missing values were
calculated (imputed) with weighted
means or with a best-subset regression
analysis (Stata reference manual, vol 2,
release 4.0; College Station, Tex: Stata
Statistical Software) and were used to
explore the effect of clinical variables by
using all the available articles to ensure
that no potentially important covariate
was overlooked.
MR angiography and duplex US were
first analyzed separately and were subse-
quently compared in one model. Univari-
ate analyses were performed to assess the
effect of each clinical covariate by using
the subset of articles with complete data
for that variable and estimated values if
necessary. The latter were used to select
variables for the final analysis only if no
TABLE 4
Clinical Characteristics of Included Studies: Duplex US
Study*
No. of
Patients†
Mean
Age
(y)
Clinical Indication Arterial Segments
Maximum
Time
(d)
Blinded
Reading of
Reference
Images/US
Images
Consecutive
Patients TP FN TN FP
CL
(%)
CI
(%)
Other
(%)
AI
(%)
F-P
(%)
IP
(%)
AbuRhama et al (22) 134 (58/42) 64 NR NR 0 33 67 0 7 Yes/Yes Yes 330 40 782 18
Aly et al (23) 90 (66/34) 68‡ 90 10 0 20 46 34 7 Yes/Yes NR 404 34 2,643 27
Arya (24) 23 (87/13) 44 NR§ NR§ 0 NR NR NR 14 Yes/Yes Yes 25 13 113 1
Bergamini et al (25) 44 (NR) NR 66 34 0 0 91 9 61 Yes/NR NR 94 24 273 13
Cossman et al (15) 61 (NR) NR NR NR 0 0 89 11 NR Yes/NR NR 139\ 20 397 4
Davies et al (16) 52 (75/25) 64‡ 100 0 0 0 100 0 14 NR NR 45 0 20 0
Karacagil et al (30) 38 (45/55) 71 16 84 0 0 8 92 14 Yes/Yes NR 211 36 186 47
Karacagil et al (29) 40 (NR) NR NR NR 0 20 60 20 50 Yes/Yes NR 66 6 227 36
Lai et al (33) 50 (NR) NR NR NR 0 22 78 0 56 Yes/Yes NR 124 42 354 38
Larch et al (35) 50 (52/48) 69 54 46 0 0 0 100 3 Yes/Yes Yes 97 11 21 21
Linke et al (36) 25 (60/40) 68 100 0 0 0 100 0 33 Yes/Yes Yes 41# 2 87 5
Moneta et al (17) 79 (98/2) 64 23 71 6 33 67 0 NR Yes/Yes Yes 188 25 236 4
Mulligan et al (18) 12 (100/0) 62 NR NR 0 24 76 0 7 NR/Yes No 25 3 89 6
Pinto et al (37) 167 (60/40) 63 55 45 0 8 64 28 14 Yes/Yes Yes 330 15 343 26
Polak et al (19) 17 (77/23) 62 59 29 12 0 100 0 0 Yes/Yes Yes 49 7 173 9
Sensier et al (41) 76 (58/42) 71‡ 88 12 0 28 45 27 19 Yes/Probably Yes 298 81 1,201 78
Whelan et al (20) 51 (NR) NR NR NR 16 0 84 16 0 Yes/Yes Yes 112** 7 462 15
Zeuchner et al (21) 50 (55/45)†† 70†† 22 78 0 39 61 0 1 Yes/Probably No 12‡‡ 4 305 1
Sensitivity analysis
Currie et al (27) 92 (74/26) 64‡ 97 3 0 100 0 0 42§§ Yes/Probably Yes 99 7 74 0
Koelemay et al (31) 23 (40/60) 71‡ 9 91 0 0 18 82 1 Yes/Yes No 136 52 48 23
Koelemay et al (32) 120 (61/39) 72‡ 16 84 0 0 17 83 13 Yes/Probably No 733 257 344 99
Note.—AI 5 aortoiliac, CI 5 critical ischemia, CL 5 intermittent claudication, F-P 5 femoropopliteal, IP 5 infrapopliteal, NR 5 not reported.
* Number in parentheses is the reference number.
† Numbers in parentheses are percentage of men/percentage of women.
‡ Median age.
§ Percentage of patients with clinical indications was not reported for verified patients but only for the total number of patients described in the study.
\ Aortoiliac disease inferred on the basis of Doppler waveform analysis of common femoral arteries; thus, aortoiliac segments were excluded.
# Cases of aneurysm seen at angiography were excluded.
** Aortoiliac disease inferred on the basis of Doppler waveform analysis of common femoral arteries; thus, aortoiliac segments were excluded. One
lesion in the superficial femoral artery was counted twice, and we subtracted this lesion from the analysis.
†† Percentages of men and women and mean age were not reported for verified patients but only for the total number of patients described in the
study.
‡‡ IP segments were excluded because no grading of stenosis was reported.
§§ Mean number of days.
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or minor differences in the results be-
tween the subset of articles with complete
data and the calculation with estimated
values were found. Significant variables
(P , .05) were subsequently assessed in a
multivariate model per examination. Vari-
ables with a P value greater than .05 but
less than .10 were retained in the model if
the explanatory power of the model in-
creased substantially (adjusted R2 in-
creased by 0.05).
In the final multivariate analysis in
which MR angiography and duplex US
were compared, missing values for signifi-
cant variables in the model were not
substituted with estimates, and only the
subset of articles with complete data for
the selected variables was used. The selec-
tion of variables for the final model was
performed by analyzing each variable in
turn and considering significant variables
alone, so as to avoid exclusion of as few
studies as possible. Also, interaction terms
were incorporated in this analysis to al-
low for differential effects, depending on
the examination. We tested for heteroge-
neity across studies by comparing the
95% CI of the observed values of the
natural logarithm of the diagnostic odds
ratio in each study with that of the pre-
dicted values of the diagnostic odds ratio
by using the final model. Finally, we
re-analyzed the final summary ROC
model with a random effects regression
analysis (Stata technical bulletin no. 42,
College Station, Tex: Stata Statistical Soft-
ware), which took interstudy variability
into account. All analyses were performed
with SPSS for Windows (release 7.5.2;
SPSS, Chicago, Ill) and STATA (release 5.0,
Stata Statistical Software) software.
Sensitivity analyses.—A so-called jack-
knife type of sensitivity analysis of the final
model was accomplished by performing
multiple summary ROC analyses and ex-
cluding each article in turn. The jackknife
sensitivity analysis is used to determine
the contribution of the results in each
article to the overall analysis. Three ar-
ticles on duplex US used another defini-
tion of disease as determined at conven-
tional angiography: Instead of 50%
stenosis, 70% stenosis was used in one
study (27), and severe vessel wall irregu-
larities were used in two others (31,32). In
a sensitivity analysis, with dummy vari-
ables for the studies with another defini-
tion of disease, we determined whether
these studies demonstrated a difference
in diagnostic performance as compared
with the other studies on duplex US. As
before, a positive coefficient indicated
increased discriminatory power, and a
negative coefficient indicated reduced dis-
criminatory power. In one study on MR
angiography (26), the authors reported
that gadolinium-based contrast material
was administered only in selected pa-
tients, and we evaluated the results in this
study by using a dummy variable for
comparison with the other MR angiogra-
phy studies.
RESULTS
Review of Studies
Our literature search resulted in 760
references, of which we retrieved 92 ar-
ticles. Sixty-seven articles were excluded
because (a) MR angiography was per-
formed without gadolinium enhance-
ment (n 5 37); (b) the absolute numbers
of TP, FN, TN, and FP results either were
not available or could not be derived (n 5
11); (c) duplex US was not color guided
(n 5 7); (d) no standard of reference was
used (n 5 4); (e) only treatment recom-
mendations were reported (n 5 3);
(f ) authors reported on the same patients
in more than one article (n 5 3); (g) no
original data were reported (n 5 1); or
(h) only results of aneurysms and vascular
grafts were reported (n 5 1). None of the
160 non–English-language articles ful-
filled the inclusion criteria for the meta-
analysis. Thirty-one articles (5–11,15–39)
met our inclusion criteria, of which six
(15–20) were available from a previous
meta-analysis (4). Three articles used an-
other definition of disease (27,31,32), and,
in one MR angiography study (26), gado-
linium enhancement was not used in all
patients. These four studies were evalu-
ated only in the sensitivity analysis, which
resulted in nine articles on MR angiogra-
phy and 18 on duplex US for the baseline
analysis.
Overall, 38 of 372 (10%) discrepancies
in data extraction occurred between the
two authors and ranged from zero to 12
of 31 (0%–39%) for the different variables
(Table 5). All discrepancies were resolved
by means of consensus. In Tables 1 and 2,
the examination characteristics of the 31
studies included in the meta-analysis are
outlined; Tables 3 and 4 present the clini-
cal characteristics. All studies but one (25)
were judged to have been prospective.
The MR angiographic results in 216 pa-
tients (from nine articles) were included
in the baseline analysis. The mean age
among patients who underwent MR angi-
ography was 63 years; 72% were men,
and 28% were women. Duplex US results
reported in 18 studies with 1,059 patients
were included in the baseline analysis.
The mean age among patients who under-
went duplex US was 65 years; 65% were
men, and 35% were women. The funnel
plot (Fig 1) for the number of analyzed
segments as a function of the discrimina-
tory power of the study (natural logarithm
of the diagnostic odds ratio) demon-
strated a symmetric funnel-shaped distribu-
tion for the duplex US studies, which sug-
gests that publication bias was unlikely to
be present. Although the MR angiographic
studies were symmetrically distributed,
there were a few with a large number of
segments; therefore, publication bias
could not be properly evaluated.
Weighted Pooled Analysis
On the basis of a random effects model,
the pooled sensitivity for MR angiogra-
phy (97.5% [95% CI: 95.7%, 99.3%]) was
TABLE 5
Discrepancies and Measures of Agreement between Two Authors
for Data Extraction from 31 Studies
Variable
No. of
Discrepancies* r Value k Value
Year of publication 0 (0) 1.00 NA
Location of study 0 (0) NA 1.00
Positivity criterion 2 (6) NA 0.63
Percentage of men 0 (0) 1.00 NA
Mean age 0 (0) 1.00 NA
Blinded reading of MR or US results 5 (16) NA 0.64
Blinded reading of reference images 1 (3) NA 0.84
Consecutive patients 7 (23) NA 0.67
Total no. of segments 12 (39) 0.99 NA
Time between MR or US and reference imaging 3 (10) 0.99 NA
Type of imager 0 (0) NA 1.00
Natural logarithm of diagnostic odds ratio 8 (26) 0.92 NA
Overall 38 of 372 (10) NA NA
Note.—The Spearman r value was calculated for continuous variables; the k value, for categoric
variables. NA 5 not applicable.
* Number in parentheses is the percentage.
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higher than that for duplex US (87.6%
[95% CI: 84.4%, 90.8%]). The pooled
specificities were similar (for MR angiogra-
phy, 96.2% [95% CI: 94.4%, 97.9%]; for
duplex US, 94.7% [95% CI: 93.2%, 96.2%]).
The pooled value of the natural loga-
rithm of the diagnostic odds ratio (Fig 1)
was 6.43 [95% CI: 5.66, 7.19] for MR angiog-
raphy and 4.99 [95% CI: 4.30, 5.68]) for
duplex US, which indicated that, overall,
the discriminatory power of MR angiogra-
phy was better than that of duplex US.
Summary ROC Analysis
No significant predictors were demon-
strated in the univariate analysis for MR
angiography, and no effect was demon-
strated for different positivity criteria (re-
gression coefficient, 0.16 [95% CI: 20.66,
0.98]; P 5 .65) The univariate analysis for
duplex US demonstrated that as the maxi-
mum number of days between duplex US
and conventional angiography increased,
the discriminatory power of duplex US
decreased [regression coefficient, 20.031
per day [95% CI: 20.060, 20.002]; P 5
.04). In the same model, the regression
coefficient for the positivity criterion of
duplex US was a significant predictor
[regression coefficient, 20.66 [95% CI:
21.14, 20.19]; P 5 .01). For both MR
angiography and duplex US, neither the
quality scores nor the individual covari-
ates for evaluating individual aspects of
quality were significant predictors of diag-
nostic performance.
In the comparison analysis, without
adjustment for covariates, the discrimina-
tory power of MR angiography (regres-
sion coefficient, 2.11 [95% CI: 0.12, 4.09])
was better than that of duplex US (P 5
.04). When we adjusted for each covariate
in turn, the discriminatory power of MR
angiography again was better than that of
duplex US, with regression coefficients of
1.18–2.27. In the comparison analysis,
the time between duplex US and conven-
tional angiography and the positivity cri-
terion were significant predictors, with
similar coefficients as in the analysis for
duplex US examination alone. Age had a
significant effect on discriminatory power,
with a regression coefficient of 20.13 per
year (95% CI: 20.250, 20.003; P 5 .05).
In the final model with adjustment for
multiple covariates, the discriminatory
power of MR angiography was better than
that of duplex US but with a slightly
lower regression coefficient of 1.67 (95%
CI: 20.23, 3.56) that only approached
statistical significance (P 5 .08). The inter-
action terms were included to allow for a
duplex US–specific effect for the maxi-
mum number of days between duplex US
and conventional angiography (regres-
sion coefficient, 20.031 per day [95% CI:
20.055, 20.006]; P 5 .02) and for the
positivity criterion (regression coeffi-
cient, 20.63 [95% CI 21.05, 20.21]; P 5
.005) (Table 6). Age was not a significant
predictor in the multivariate model. The
adjusted R2 value for the final model was
0.41. Figure 2 presents the summary
ROC curves determined on the basis
of the final model for MR angiography
and duplex US, adjusted to 0 days be-
tween duplex US and conventional angi-
ography.
Heterogeneity
The 95% CI of the observed discrimina-
tory power of each examination was com-
pared with the 95% CI of the values
predicted with the final model. The pre-
dicted values from the MR angiographic
studies all fell within the observed 95%
CIs, which was indicative of homogene-
ity. The same was true for all but three of
the duplex US articles. The three articles
were by Pinto et al (37), who reported
very high sensitivity (96%); Aly et al (23),
who reported high sensitivity (92%) and
specificity (99%); and Sensier et al (39),
who reported low sensitivity (79%). Appli-
cation of a random effects regression
analysis to the final summary ROC model
to account for the unexplained heteroge-
neity demonstrated that the discrimina-
tory power of MR angiography was better
than that of duplex US, with a regression
coefficient of 1.73 (95% CI: 0.44, 3.02;
P 5 .009).
Figure 1. Funnel plot shows discriminatory power (D, natural
logarithm of diagnostic odds ratio) versus number of segments
evaluated for pooled data from MR angiography (solid line) and
duplex US (dotted line) studies. The pooled discriminatory power for
MR angiography is greater than that for duplex US, which indicates
that the diagnostic performance of MR angiography was better than
that of duplex US. Horizontal error bars 5 95% CI, j 5 MR results
from individual studies, X 5 US results from individual studies. The
distribution of data points looks fairly funnel-shaped and symmetric
for duplex US, which suggests that publication bias was unlikely. For
MR angiography, there were too few studies with a large number of
segments to enable evaluation of publication bias.
TABLE 6
Final Model for Comparison between MR Angiography and Duplex US
Variable
Regression
Coefficient* P Value
Adjusted
R2 Value†
MR angiography versus duplex US 1.67 (20.23, 3.56) .08 NA
Time between US and conventional
angiography 20.031 (20.055, 20.006)‡ .02 NA
Positivity criterion for duplex US 20.63 (21.05, 20.21) .005 0.41
* Numbers in parentheses are the 95% CI.
† NA 5 not applicable.
‡ Value is the change per day.
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Sensitivity Analyses
Exclusion of all articles, one by one,
from the final model did not have a large
effect on the difference in discriminatory
power between MR angiography and du-
plex US (regression coefficient range,
1.33–2.14). In a sensitivity analysis, we
included three duplex US studies in which
another definition of disease or another
positivity criterion was used. The study
with another percentage of diameter re-
duction as the definition of disease (27)
demonstrated better discriminatory
power, but this difference was not signifi-
cant in comparison with results from the
other duplex US studies (regression coeffi-
cient, 2.66 [95% CI: 26.93, 12.25]; P 5
.56). The two studies by Koelemay et al
(31,32) used irregularities of the vessel
wall and luminal narrowing seen at du-
plex US as positivity criteria and severe
vessel wall irregularities seen at conven-
tional angiography as the definition of
disease. Results from these two studies
demonstrated a discriminatory power that
was lower than those of the other duplex
US studies (regression coefficient, 22.16
[95% CI: 23.21, 21.10]; P 5 .001). In the
study by Cambria et al (26), a gadolinium-
based contrast agent was administered
only in selected patients, which de-
creased the discriminatory power relative
to that of the other MR angiography
studies (regression coefficient, 22.20 [95%
CI: 23.92, 20.49]; P 5 .02).
DISCUSSION
The current meta-analysis compared
gadolinium-enhanced MR angiography
and color-guided duplex US for the evalu-
ation of stenoses and occlusions in the
work-up for peripheral arterial disease of
the lower extremities. The results suggest
that the discriminatory power of MR angi-
ography was better than that of duplex
US, which was demonstrated both with
the summary ROC results and with the
pooled weighted estimates. In compari-
son with conventional angiography, both
imaging modalities provided good diag-
nostic performance. Both had high speci-
ficity, but the sensitivity of duplex US was
lower than that of MR angiography. The
analysis also demonstrated that an in-
crease in time between duplex US and
conventional angiography resulted in a
decrease in the discriminatory power of
duplex US.
A limitation of pooling sensitivities and
specificities is that different positivity cri-
teria used in individual studies are not
taken into account. Summary ROC analy-
sis, on the other hand, allows adjustment
for different positivity criteria. Further-
more, summary ROC analysis can be ex-
tended to a multivariate regression analy-
sis to adjust for differences in patient
characteristics, study design, and diagnos-
tic imaging protocols. Adjustment for
these differences was limited in our analy-
sis, however, because not all articles in-
cluded the relevant details. For example,
the mean age of patients was not always
reported. The results based on compara-
tive summary ROC analysis of the subset
of studies in which mean age was re-
ported suggested that both types of stud-
ies had lower discriminatory power in
elderly patients, but firm conclusions
about the effect of age cannot be made.
Furthermore, the percentage of patients
with intermittent claudication and the
percentages of male and female patients
could not be extracted from all articles.
Finally, although most of the duplex US
articles reported site-specific results, only
five of the nine MR angiography articles
did so, which made a comparative sub-
group analysis by anatomic site imprac-
tical. We did, however, adjust for the
proportion of femoropopliteal and infra-
popliteal segments in our analysis and
found no difference in effect with this
adjustment.
As with all meta-analyses, the present
study was limited by the ambiguity of the
originally reported data. This ambiguity
can lead to differences in interpretation
and discrepancies in extraction of data.
To minimize the bias due to this limita-
tion, both authors extracted the data
independently. Discrepancies occurred in
10% of the extracted data points. Overall,
the authors demonstrated good agree-
ment with regard to the extracted infor-
mation, with k values ranging from 0.63
to 1.00 and correlation coefficients
(r values) ranging from 0.92 to 1.00.
Another limitation of meta-analyses is
that the quality of the original studies
may affect the results. L’Abbe´ et al (49)
recommended that a quality score be
calculated for studies included in a meta-
analysis. In our analysis, we evaluated the
quality of the study design and reporting
methods by distinguishing studies that
fulfilled all quality criteria versus those
that did not and by using a published
rating score (48) for the quality of diagnos-
tic imaging studies. In the summary ROC
analysis, neither the quality scores nor
the individual covariates that constituted
the quality score were significant predic-
tors of diagnostic performance.
Publication bias may have affected our
results. Although we demonstrated that
publication bias was unlikely to be pres-
Figure 2. Summary ROC (SROC) curves for MR angiography and
duplex US based on the final model, adjusted to 0 days between
duplex US and conventional angiography. The summary ROC curve
for MR angiography is further to the upper left than is that of duplex
US, indicating that the discriminatory power of MR angiography was
better than that of duplex US.
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ent for duplex US studies, we cannot
exclude such bias, because the limited
number of data points could have de-
creased the power of detecting publica-
tion bias with the funnel plot. Moreover,
the limited number of MR angiography
studies, all of which included relatively
small numbers of patients, did not enable
us to detect whether publication bias was
present. Another potential issue related
to publication bias is that early reports of
diagnostic test results generally are more
favorable. This could have potentially
biased the results against duplex US, be-
cause publications on duplex US have
appeared since the early 1980s, whereas
gadolinium-enhanced MR angiography
was first performed in the early 1990s. To
determine whether this may have influ-
enced the results, we evaluated the effect
of publication year and found that the
discriminatory power of MR angiography
and duplex US did not change over the
years.
In general, the time between MR angi-
ography and conventional angiography
was shorter (#14 days; mean, 5 days)
than that between duplex US and conven-
tional angiography (#61 days; mean, 17
days). With an increase in the period
between the comparison examination
(MR angiography or duplex US) and the
reference standard examination (conven-
tional angiography), one would expect a
greater change in the disease status due,
for example, to progression of disease
(50). Thus, with an increase in the time
between the comparison and the refer-
ence examinations, one can expect a de-
crease in the discriminatory power of the
comparison examination, which was in-
deed demonstrated in this analysis for
duplex US. In fact, the lower discrimina-
tory power of duplex US as compared
with MR angiography was explained in
part by the longer time between duplex
US and conventional angiography rela-
tive to that between MR angiography and
conventional angiography. This implies
that the comparison and reference exam-
inations should ideally be performed on
the same day and that comparisons be-
tween MR angiography and duplex US
should take this factor into account,
which we did by adjusting for this vari-
able in the final model.
The reported sensitivities for duplex US
span a broad range, which may be ex-
plained by the fairly long delay between
US and conventional angiography (dis-
cussed in the preceding paragraph), opera-
tor dependency, differences in technique,
variation among duplex US machines, or
differences in patient populations. Re-
sults from a previous study (51) in which
US assessment of carotid arterial stenosis
was evaluated suggested that differences
in the hardware or software of duplex US
machines could cause discrepancies in
measured velocities. We could not, how-
ever, detect a difference in diagnostic
performance for different duplex US ma-
chines.
Questions have been raised concerning
the use of conventional angiography as
the reference standard for comparison
with MR angiography. Owen et al (52)
and Carpenter et al (53) reported that
conventional angiography may not be a
good reference method for demonstrat-
ing runoff vessels, because MR angiogra-
phy demonstrated more patent vessels
than did conventional angiography. Thus,
some authors (26,42) reported a measure
of agreement (k statistic) rather than the
sensitivity and specificity for the compari-
son of MR angiographic results with con-
ventional angiographic results. Cambria
et al (26) reported k values of 0.48–0.60,
and Quinn et al (42) reported substantial
to perfect agreement (k 5 0.61–1.00) for
nearly all anatomic segments.
The authors of three articles on MR
angiography (8,10,38) compared differ-
ent techniques for performing the exami-
nation. In our meta-analysis, we included
only the results of gadolinium-enhanced
MR angiography because gadolinium en-
hancement has rapidly become the stan-
dard and has been shown to substantially
improve the diagnostic performance of
MR angiography (8,38,54). With the on-
going technical developments in MR im-
aging, one can expect future improve-
ments in the discriminatory power of MR
angiography. Major improvements in du-
plex US are less likely, although the use of
intravascular contrast agents could poten-
tially improve this method, as well. Such
improvements may necessitate an update
of the meta-analysis in the future.
Ideally, MR angiography and duplex US
should be compared in the same group of
patients or should be randomly assigned
to groups of patients (14). The literature
search did not retrieve any articles in
which gadolinium-enhanced MR angiog-
raphy was compared directly with color-
guided duplex US. It is possible that the
demonstrated differences in our analysis
of diagnostic performance between MR
angiography and duplex US may reflect
differences in study or patient characteris-
tics. In fact, the current results suggest
that part of the superiority in diagnostic
performance of MR angiography, as com-
pared with that of duplex US, was ex-
plained by such differences. Furthermore,
it should be noted that both examina-
tions were performed in highly selected
patient populations. Almost all studies
were conducted in an academic setting in
either North America or Europe and in-
cluded patients usually scheduled for pre-
interventional work-up for peripheral ar-
terial disease. Widespread use of MR
angiography and duplex US in patients
with broader clinical indications might
result in different diagnostic performance
of these examinations; therefore, general-
ization of our results should be made
with caution.
The goal of imaging in the work-up for
peripheral arterial disease is not to dis-
criminate between patients with and
those without disease (the history and
ankle-brachial index do that), but rather
to discriminate between diseased and
nondiseased segments, that is, to localize
the disease. Thus, in determining the
sensitivity and specificity of imaging ex-
aminations for peripheral arterial disease,
data analysis according to segment prob-
ably is the most relevant, and, in all
articles but one (16), results were indeed
reported according to segment rather than
according to limb or patient. This would
imply that multiple segments per patient
were analyzed in each study and that
observations within each study may have
been correlated. Correlation of the obser-
vations within each study is a characteris-
tic of the individual study results and
does not imply that the data points used
in a meta-analysis are correlated. In a
meta-analysis, potential bias related to
this problem can be adjusted if the corre-
lations in the individual studies are known,
which generally is not the case. Neverthe-
less, the fact that disease severity in arte-
rial segments is correlated within a pa-
tient does not necessarily mean that the
diagnostic performance is correlated as
well.
Ultimately, diagnostic information ac-
cording to segment must be integrated to
enable treatment decision making for the
patient. Evaluation and optimization of
the decision-making process will require
an extensive analysis that must take into
account not only the diagnostic accura-
cies of the examination, as presented
here, but also the effects of imaging on
treatment planning, prognosis, quality of
life, local expertise, availability of equip-
ment, and costs.
In conclusion, our results suggest that
the discriminatory power of gadolinium-
enhanced MR angiography was better
than that of color-guided duplex US and
that MR angiography was a highly sensi-
tive and specific method, as compared
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with conventional angiography, for the
work-up for peripheral arterial disease,
which implies that MR angiography could
potentially replace duplex US and conven-
tional angiography.
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